Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Fexofenadine Market Growth 2022-2028

  • LP 4792853
  • 115 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Fexofenadine will have significant change from previous year. According to our (LP Information) latest study, the global Fexofenadine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Fexofenadine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Fexofenadine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fexofenadine market, reaching US$ million by the year 2028. As for the Europe Fexofenadine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Fexofenadine players cover Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, and Titan Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Fexofenadine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Purity:98%

Purity:Above 98%

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hay Fever Treatment

Urticaria Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Viruj Pharma

Cemex Pharma

Smaart Pharmaceutticals

Titan Pharma

AFCL

Synkromax

Farmhispania

Gen Pharma

Admiron Life Sciences Private Limited

JRC

Archerchem

Sibram

Sumitomo Chemical

Panchsheel

CAMEO HEALTH CARE

CEPiA-Sanofi

Va Sudha Pharma Chem Limited

VPL Chemicals

Zhejiang Excel Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Fexofenadine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Fexofenadine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Fexofenadine by Country/Region, 2017, 2022 & 2028

2.2 Fexofenadine Segment by Type

2.2.1 Purity:98%

2.2.2 Purity:Above 98%

2.3 Fexofenadine Sales by Type

2.3.1 Global Fexofenadine Sales Market Share by Type (2017-2022)

2.3.2 Global Fexofenadine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Fexofenadine Sale Price by Type (2017-2022)

2.4 Fexofenadine Segment by Application

2.4.1 Hay Fever Treatment

2.4.2 Urticaria Treatment

2.5 Fexofenadine Sales by Application

2.5.1 Global Fexofenadine Sale Market Share by Application (2017-2022)

2.5.2 Global Fexofenadine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Fexofenadine Sale Price by Application (2017-2022)

3 Global Fexofenadine by Company

3.1 Global Fexofenadine Breakdown Data by Company

3.1.1 Global Fexofenadine Annual Sales by Company (2020-2022)

3.1.2 Global Fexofenadine Sales Market Share by Company (2020-2022)

3.2 Global Fexofenadine Annual Revenue by Company (2020-2022)

3.2.1 Global Fexofenadine Revenue by Company (2020-2022)

3.2.2 Global Fexofenadine Revenue Market Share by Company (2020-2022)

3.3 Global Fexofenadine Sale Price by Company

3.4 Key Manufacturers Fexofenadine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Fexofenadine Product Location Distribution

3.4.2 Players Fexofenadine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Fexofenadine by Geographic Region

4.1 World Historic Fexofenadine Market Size by Geographic Region (2017-2022)

4.1.1 Global Fexofenadine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Fexofenadine Annual Revenue by Geographic Region

4.2 World Historic Fexofenadine Market Size by Country/Region (2017-2022)

4.2.1 Global Fexofenadine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Fexofenadine Annual Revenue by Country/Region

4.3 Americas Fexofenadine Sales Growth

4.4 APAC Fexofenadine Sales Growth

4.5 Europe Fexofenadine Sales Growth

4.6 Middle East & Africa Fexofenadine Sales Growth

5 Americas

5.1 Americas Fexofenadine Sales by Country

5.1.1 Americas Fexofenadine Sales by Country (2017-2022)

5.1.2 Americas Fexofenadine Revenue by Country (2017-2022)

5.2 Americas Fexofenadine Sales by Type

5.3 Americas Fexofenadine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Fexofenadine Sales by Region

6.1.1 APAC Fexofenadine Sales by Region (2017-2022)

6.1.2 APAC Fexofenadine Revenue by Region (2017-2022)

6.2 APAC Fexofenadine Sales by Type

6.3 APAC Fexofenadine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Fexofenadine by Country

7.1.1 Europe Fexofenadine Sales by Country (2017-2022)

7.1.2 Europe Fexofenadine Revenue by Country (2017-2022)

7.2 Europe Fexofenadine Sales by Type

7.3 Europe Fexofenadine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Fexofenadine by Country

8.1.1 Middle East & Africa Fexofenadine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Fexofenadine Revenue by Country (2017-2022)

8.2 Middle East & Africa Fexofenadine Sales by Type

8.3 Middle East & Africa Fexofenadine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Fexofenadine

10.3 Manufacturing Process Analysis of Fexofenadine

10.4 Industry Chain Structure of Fexofenadine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Fexofenadine Distributors

11.3 Fexofenadine Customer

12 World Forecast Review for Fexofenadine by Geographic Region

12.1 Global Fexofenadine Market Size Forecast by Region

12.1.1 Global Fexofenadine Forecast by Region (2023-2028)

12.1.2 Global Fexofenadine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Fexofenadine Forecast by Type

12.7 Global Fexofenadine Forecast by Application

13 Key Players Analysis

13.1 Viruj Pharma

13.1.1 Viruj Pharma Company Information

13.1.2 Viruj Pharma Fexofenadine Product Offered

13.1.3 Viruj Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Viruj Pharma Main Business Overview

13.1.5 Viruj Pharma Latest Developments

13.2 Cemex Pharma

13.2.1 Cemex Pharma Company Information

13.2.2 Cemex Pharma Fexofenadine Product Offered

13.2.3 Cemex Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cemex Pharma Main Business Overview

13.2.5 Cemex Pharma Latest Developments

13.3 Smaart Pharmaceutticals

13.3.1 Smaart Pharmaceutticals Company Information

13.3.2 Smaart Pharmaceutticals Fexofenadine Product Offered

13.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Smaart Pharmaceutticals Main Business Overview

13.3.5 Smaart Pharmaceutticals Latest Developments

13.4 Titan Pharma

13.4.1 Titan Pharma Company Information

13.4.2 Titan Pharma Fexofenadine Product Offered

13.4.3 Titan Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Titan Pharma Main Business Overview

13.4.5 Titan Pharma Latest Developments

13.5 AFCL

13.5.1 AFCL Company Information

13.5.2 AFCL Fexofenadine Product Offered

13.5.3 AFCL Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AFCL Main Business Overview

13.5.5 AFCL Latest Developments

13.6 Synkromax

13.6.1 Synkromax Company Information

13.6.2 Synkromax Fexofenadine Product Offered

13.6.3 Synkromax Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Synkromax Main Business Overview

13.6.5 Synkromax Latest Developments

13.7 Farmhispania

13.7.1 Farmhispania Company Information

13.7.2 Farmhispania Fexofenadine Product Offered

13.7.3 Farmhispania Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Farmhispania Main Business Overview

13.7.5 Farmhispania Latest Developments

13.8 Gen Pharma

13.8.1 Gen Pharma Company Information

13.8.2 Gen Pharma Fexofenadine Product Offered

13.8.3 Gen Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Gen Pharma Main Business Overview

13.8.5 Gen Pharma Latest Developments

13.9 Admiron Life Sciences Private Limited

13.9.1 Admiron Life Sciences Private Limited Company Information

13.9.2 Admiron Life Sciences Private Limited Fexofenadine Product Offered

13.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Admiron Life Sciences Private Limited Main Business Overview

13.9.5 Admiron Life Sciences Private Limited Latest Developments

13.10 JRC

13.10.1 JRC Company Information

13.10.2 JRC Fexofenadine Product Offered

13.10.3 JRC Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 JRC Main Business Overview

13.10.5 JRC Latest Developments

13.11 Archerchem

13.11.1 Archerchem Company Information

13.11.2 Archerchem Fexofenadine Product Offered

13.11.3 Archerchem Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Archerchem Main Business Overview

13.11.5 Archerchem Latest Developments

13.12 Sibram

13.12.1 Sibram Company Information

13.12.2 Sibram Fexofenadine Product Offered

13.12.3 Sibram Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sibram Main Business Overview

13.12.5 Sibram Latest Developments

13.13 Sumitomo Chemical

13.13.1 Sumitomo Chemical Company Information

13.13.2 Sumitomo Chemical Fexofenadine Product Offered

13.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sumitomo Chemical Main Business Overview

13.13.5 Sumitomo Chemical Latest Developments

13.14 Panchsheel

13.14.1 Panchsheel Company Information

13.14.2 Panchsheel Fexofenadine Product Offered

13.14.3 Panchsheel Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Panchsheel Main Business Overview

13.14.5 Panchsheel Latest Developments

13.15 CAMEO HEALTH CARE

13.15.1 CAMEO HEALTH CARE Company Information

13.15.2 CAMEO HEALTH CARE Fexofenadine Product Offered

13.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CAMEO HEALTH CARE Main Business Overview

13.15.5 CAMEO HEALTH CARE Latest Developments

13.16 CEPiA-Sanofi

13.16.1 CEPiA-Sanofi Company Information

13.16.2 CEPiA-Sanofi Fexofenadine Product Offered

13.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 CEPiA-Sanofi Main Business Overview

13.16.5 CEPiA-Sanofi Latest Developments

13.17 Va Sudha Pharma Chem Limited

13.17.1 Va Sudha Pharma Chem Limited Company Information

13.17.2 Va Sudha Pharma Chem Limited Fexofenadine Product Offered

13.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Va Sudha Pharma Chem Limited Main Business Overview

13.17.5 Va Sudha Pharma Chem Limited Latest Developments

13.18 VPL Chemicals

13.18.1 VPL Chemicals Company Information

13.18.2 VPL Chemicals Fexofenadine Product Offered

13.18.3 VPL Chemicals Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 VPL Chemicals Main Business Overview

13.18.5 VPL Chemicals Latest Developments

13.19 Zhejiang Excel Pharmaceutical

13.19.1 Zhejiang Excel Pharmaceutical Company Information

13.19.2 Zhejiang Excel Pharmaceutical Fexofenadine Product Offered

13.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Zhejiang Excel Pharmaceutical Main Business Overview

13.19.5 Zhejiang Excel Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Fexofenadine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Fexofenadine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Purity:98%

Table 4. Major Players of Purity:Above 98%

Table 5. Global Fexofenadine Sales by Type (2017-2022) & (MT)

Table 6. Global Fexofenadine Sales Market Share by Type (2017-2022)

Table 7. Global Fexofenadine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Fexofenadine Revenue Market Share by Type (2017-2022)

Table 9. Global Fexofenadine Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Fexofenadine Sales by Application (2017-2022) & (MT)

Table 11. Global Fexofenadine Sales Market Share by Application (2017-2022)

Table 12. Global Fexofenadine Revenue by Application (2017-2022)

Table 13. Global Fexofenadine Revenue Market Share by Application (2017-2022)

Table 14. Global Fexofenadine Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Fexofenadine Sales by Company (2020-2022) & (MT)

Table 16. Global Fexofenadine Sales Market Share by Company (2020-2022)

Table 17. Global Fexofenadine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Fexofenadine Revenue Market Share by Company (2020-2022)

Table 19. Global Fexofenadine Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Fexofenadine Producing Area Distribution and Sales Area

Table 21. Players Fexofenadine Products Offered

Table 22. Fexofenadine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Fexofenadine Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Fexofenadine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Fexofenadine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Fexofenadine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Fexofenadine Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Fexofenadine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Fexofenadine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Fexofenadine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Fexofenadine Sales by Country (2017-2022) & (MT)

Table 34. Americas Fexofenadine Sales Market Share by Country (2017-2022)

Table 35. Americas Fexofenadine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Fexofenadine Revenue Market Share by Country (2017-2022)

Table 37. Americas Fexofenadine Sales by Type (2017-2022) & (MT)

Table 38. Americas Fexofenadine Sales Market Share by Type (2017-2022)

Table 39. Americas Fexofenadine Sales by Application (2017-2022) & (MT)

Table 40. Americas Fexofenadine Sales Market Share by Application (2017-2022)

Table 41. APAC Fexofenadine Sales by Region (2017-2022) & (MT)

Table 42. APAC Fexofenadine Sales Market Share by Region (2017-2022)

Table 43. APAC Fexofenadine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Fexofenadine Revenue Market Share by Region (2017-2022)

Table 45. APAC Fexofenadine Sales by Type (2017-2022) & (MT)

Table 46. APAC Fexofenadine Sales Market Share by Type (2017-2022)

Table 47. APAC Fexofenadine Sales by Application (2017-2022) & (MT)

Table 48. APAC Fexofenadine Sales Market Share by Application (2017-2022)

Table 49. Europe Fexofenadine Sales by Country (2017-2022) & (MT)

Table 50. Europe Fexofenadine Sales Market Share by Country (2017-2022)

Table 51. Europe Fexofenadine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Fexofenadine Revenue Market Share by Country (2017-2022)

Table 53. Europe Fexofenadine Sales by Type (2017-2022) & (MT)

Table 54. Europe Fexofenadine Sales Market Share by Type (2017-2022)

Table 55. Europe Fexofenadine Sales by Application (2017-2022) & (MT)

Table 56. Europe Fexofenadine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Fexofenadine Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Fexofenadine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Fexofenadine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Fexofenadine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Fexofenadine Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Fexofenadine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Fexofenadine Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Fexofenadine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Fexofenadine

Table 66. Key Market Challenges & Risks of Fexofenadine

Table 67. Key Industry Trends of Fexofenadine

Table 68. Fexofenadine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Fexofenadine Distributors List

Table 71. Fexofenadine Customer List

Table 72. Global Fexofenadine Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Fexofenadine Sales Market Forecast by Region

Table 74. Global Fexofenadine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Fexofenadine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Fexofenadine Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Fexofenadine Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Fexofenadine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Fexofenadine Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Fexofenadine Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Fexofenadine Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Fexofenadine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Fexofenadine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Fexofenadine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Fexofenadine Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Fexofenadine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Fexofenadine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Fexofenadine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Viruj Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 93. Viruj Pharma Fexofenadine Product Offered

Table 94. Viruj Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Viruj Pharma Main Business

Table 96. Viruj Pharma Latest Developments

Table 97. Cemex Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 98. Cemex Pharma Fexofenadine Product Offered

Table 99. Cemex Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Cemex Pharma Main Business

Table 101. Cemex Pharma Latest Developments

Table 102. Smaart Pharmaceutticals Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 103. Smaart Pharmaceutticals Fexofenadine Product Offered

Table 104. Smaart Pharmaceutticals Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Smaart Pharmaceutticals Main Business

Table 106. Smaart Pharmaceutticals Latest Developments

Table 107. Titan Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 108. Titan Pharma Fexofenadine Product Offered

Table 109. Titan Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Titan Pharma Main Business

Table 111. Titan Pharma Latest Developments

Table 112. AFCL Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 113. AFCL Fexofenadine Product Offered

Table 114. AFCL Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. AFCL Main Business

Table 116. AFCL Latest Developments

Table 117. Synkromax Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 118. Synkromax Fexofenadine Product Offered

Table 119. Synkromax Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Synkromax Main Business

Table 121. Synkromax Latest Developments

Table 122. Farmhispania Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 123. Farmhispania Fexofenadine Product Offered

Table 124. Farmhispania Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Farmhispania Main Business

Table 126. Farmhispania Latest Developments

Table 127. Gen Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 128. Gen Pharma Fexofenadine Product Offered

Table 129. Gen Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Gen Pharma Main Business

Table 131. Gen Pharma Latest Developments

Table 132. Admiron Life Sciences Private Limited Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 133. Admiron Life Sciences Private Limited Fexofenadine Product Offered

Table 134. Admiron Life Sciences Private Limited Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Admiron Life Sciences Private Limited Main Business

Table 136. Admiron Life Sciences Private Limited Latest Developments

Table 137. JRC Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 138. JRC Fexofenadine Product Offered

Table 139. JRC Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. JRC Main Business

Table 141. JRC Latest Developments

Table 142. Archerchem Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 143. Archerchem Fexofenadine Product Offered

Table 144. Archerchem Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Archerchem Main Business

Table 146. Archerchem Latest Developments

Table 147. Sibram Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 148. Sibram Fexofenadine Product Offered

Table 149. Sibram Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. Sibram Main Business

Table 151. Sibram Latest Developments

Table 152. Sumitomo Chemical Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 153. Sumitomo Chemical Fexofenadine Product Offered

Table 154. Sumitomo Chemical Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 155. Sumitomo Chemical Main Business

Table 156. Sumitomo Chemical Latest Developments

Table 157. Panchsheel Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 158. Panchsheel Fexofenadine Product Offered

Table 159. Panchsheel Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 160. Panchsheel Main Business

Table 161. Panchsheel Latest Developments

Table 162. CAMEO HEALTH CARE Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 163. CAMEO HEALTH CARE Fexofenadine Product Offered

Table 164. CAMEO HEALTH CARE Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 165. CAMEO HEALTH CARE Main Business

Table 166. CAMEO HEALTH CARE Latest Developments

Table 167. CEPiA-Sanofi Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 168. CEPiA-Sanofi Fexofenadine Product Offered

Table 169. CEPiA-Sanofi Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 170. CEPiA-Sanofi Main Business

Table 171. CEPiA-Sanofi Latest Developments

Table 172. Va Sudha Pharma Chem Limited Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 173. Va Sudha Pharma Chem Limited Fexofenadine Product Offered

Table 174. Va Sudha Pharma Chem Limited Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 175. Va Sudha Pharma Chem Limited Main Business

Table 176. Va Sudha Pharma Chem Limited Latest Developments

Table 177. VPL Chemicals Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 178. VPL Chemicals Fexofenadine Product Offered

Table 179. VPL Chemicals Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 180. VPL Chemicals Main Business

Table 181. VPL Chemicals Latest Developments

Table 182. Zhejiang Excel Pharmaceutical Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors

Table 183. Zhejiang Excel Pharmaceutical Fexofenadine Product Offered

Table 184. Zhejiang Excel Pharmaceutical Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 185. Zhejiang Excel Pharmaceutical Main Business

Table 186. Zhejiang Excel Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Fexofenadine

Figure 2. Fexofenadine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Fexofenadine Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Fexofenadine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Fexofenadine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Purity:98%

Figure 10. Product Picture of Purity:Above 98%

Figure 11. Global Fexofenadine Sales Market Share by Type in 2021

Figure 12. Global Fexofenadine Revenue Market Share by Type (2017-2022)

Figure 13. Fexofenadine Consumed in Hay Fever Treatment

Figure 14. Global Fexofenadine Market: Hay Fever Treatment (2017-2022) & (MT)

Figure 15. Fexofenadine Consumed in Urticaria Treatment

Figure 16. Global Fexofenadine Market: Urticaria Treatment (2017-2022) & (MT)

Figure 17. Global Fexofenadine Sales Market Share by Application (2017-2022)

Figure 18. Global Fexofenadine Revenue Market Share by Application in 2021

Figure 19. Fexofenadine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Fexofenadine Revenue Market Share by Company in 2021

Figure 21. Global Fexofenadine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Fexofenadine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Fexofenadine Sales Market Share by Region (2017-2022)

Figure 24. Global Fexofenadine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Fexofenadine Sales 2017-2022 (MT)

Figure 26. Americas Fexofenadine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Fexofenadine Sales 2017-2022 (MT)

Figure 28. APAC Fexofenadine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Fexofenadine Sales 2017-2022 (MT)

Figure 30. Europe Fexofenadine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Fexofenadine Sales 2017-2022 (MT)

Figure 32. Middle East & Africa Fexofenadine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Fexofenadine Sales Market Share by Country in 2021

Figure 34. Americas Fexofenadine Revenue Market Share by Country in 2021

Figure 35. United States Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Fexofenadine Sales Market Share by Region in 2021

Figure 40. APAC Fexofenadine Revenue Market Share by Regions in 2021

Figure 41. China Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Fexofenadine Sales Market Share by Country in 2021

Figure 48. Europe Fexofenadine Revenue Market Share by Country in 2021

Figure 49. Germany Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Fexofenadine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Fexofenadine Revenue Market Share by Country in 2021

Figure 56. Egypt Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Fexofenadine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Fexofenadine in 2021

Figure 62. Manufacturing Process Analysis of Fexofenadine

Figure 63. Industry Chain Structure of Fexofenadine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390